Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Admicom Oyj ADMCM Sep 20, 2019 51.20 +1.99   
 Afarak Group AFAGR Sep 20, 2019 0.64 -0.63   
 Ahlstrom-Munksjö AM1S Sep 20, 2019 154.80 +0.13   
 Ahlstrom-Munksjö AM1 Sep 20, 2019 14.70 +1.52   
 Ahola Transport AHOLA Sep 20, 2019 0.84 0.00   
 Aktia Bank AKTIA Sep 20, 2019 8.48 +0.47   
 Alma Media ALMA Sep 20, 2019 6.72 -0.89   
 Altia ALTIA Sep 20, 2019 7.53 -0.26   
 Apetit APETIT Sep 20, 2019 7.88 0.00   
 Asiakastieto Group ATG1V Sep 20, 2019 27.60 +2.99   
 Aspo ASPO Sep 20, 2019 8.66 -1.14   
 Aspocomp Group ACG1V Sep 20, 2019 5.24 +0.77   
 Atria A ATRAV Sep 20, 2019 7.45 +0.27   
 Basware BAS1V Sep 20, 2019 23.00 +0.22   
 BBS-Bioactive Bone Substitutes BONEH Sep 20, 2019 2.30 +5.50   
 Biohit B BIOBV Sep 20, 2019 2.48 0.00   
 Bittium BITTI Sep 20, 2019 6.39 -2.14   
 CapMan CAPMAN Sep 20, 2019 1.89 +0.53   
 Cargotec CGCBV Sep 20, 2019 30.06 -1.18   
 Caverion CAV1V Sep 20, 2019 5.71 -1.55   
 Citycon CTY1S Sep 20, 2019 9.55 +0.34   
 Componenta CTH1V Sep 20, 2019 0.14 +2.20   
 Consti Yhtiöt CONSTI Sep 20, 2019 5.18 +0.78   
 Cramo CRA1V Sep 20, 2019 9.05 -3.42   
 Detection Technology DETEC Sep 20, 2019 21.20 -5.36   
 Digia DIGIA Sep 20, 2019 3.84 +2.95   
 Digitalist Group DIGIGR Sep 20, 2019 0.05 0.00   
 DNA DNA Sep 20, 2019 20.88 0.00   
 Dovre Group DOV1V Sep 20, 2019 0.24 -0.42   
 EAB Group EAB Sep 20, 2019 2.92 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK